6.4.8. guidelines second-line therapy treatment curative intent. local salvage treatmentstrength ratingrecommendations biochemical recurrence (bcr) radical prostatectomyoffer early salvage intensity-modulated radiotherapy/volumetric arc radiation therapy plus image-guided radiotherapy men two consecutive psa rises.stronga negative positron emission tomography/computed tomography (pet/ct) scan delay salvage radiotherapy (srt), otherwise indicated.strongoffer monitoring, including prostate-specific antigen (psa), eau low-risk bcr patients.weakdo wait psa threshold starting treatment. decision srt made, srt (at least 64 gy) given soon possible.strongoffer hormonal therapy addition srt men bcr.weakrecommendations bcr radiotherapyoffer monitoring, including psa eau low-risk bcr patients.weakonly offer salvage radical prostatectomy (rp), brachytherapy, stereotactic body radiotherapy, high-intensity focused ultrasound, cryosurgical ablation highly selected patients biopsy-proven local recurrence within clinical trial setting well-designed prospective cohort study undertaken experienced centres.strongrecommendations systemic salvage treatmentdo offer androgen deprivation therapy m0 patients psa-doubling time > twelve months.strongoffer enzalutamide without androgen deprivation therapy m0 patients high-risk bcr, defined psa doubling time ≤9 months psa level ≥2ng/ml nadir radiation therapy ≥1 ng/ml radical prostatectomy without postoperative radiation therapy.strongrecommendations follow-up radical prostatectomy radiotherapyroutinely follow-up asymptomatic patients obtaining least disease-specific history serum prostate-specific antigen (psa) measurement.strongat recurrence, perform imaging result affect treatment planning.strong